Ingredients

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

Your API is about to graduate to clinical trial manufacturing. Now what?!

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

A drug development story: how one company filed a marketing authorization in Europe for a botanical drug to treat alopecia areata.

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.